✦ LIBER ✦
Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial
✍ Scribed by The BRAION study group; Barbara Wilhelm; Holger Lüdtke; Helmut Wilhelm
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 137 KB
- Volume
- 244
- Category
- Article
- ISSN
- 0065-6100
No coin nor oath required. For personal study only.